Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/03/2008 | WO2008079055A1 1-hydroxy-hermatrane salts with oxy-, keto- and poly-carboxylic acids |
07/03/2008 | WO2008078723A1 Antibacterial agent and bactericidal agent |
07/03/2008 | WO2008078411A1 Pharmaceutical agent for prevention and/or treatment of inflammatory myopathy |
07/03/2008 | WO2008078331A1 Medicinal formulation for the treatment for hepatitis c |
07/03/2008 | WO2008077651A1 Pyrido(3,2-d)pyrimidines useful for treating viral infections |
07/03/2008 | WO2008077650A1 Pyrido(3,2-d)pyrimidines useful for treating viral infections |
07/03/2008 | WO2008077649A1 Pyrido(3,2-d)pyrimidines useful for treating viral infectons |
07/03/2008 | WO2008077618A1 Use of xanthohumol and/or isoxanthohumol as an agent for preventing and/or combating liver diseases |
07/03/2008 | WO2008077404A1 Substituted acetophenones useful as pde4 inhibitors |
07/03/2008 | WO2008077251A1 Growth inhibition and elimination of methicillin-resistant staphylococcus aureus by lactic acid bacteria |
07/03/2008 | WO2008077241A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
07/03/2008 | WO2008077229A1 Growth inhibition of microorganisms by lactic acid bacteria |
07/03/2008 | WO2008077188A1 Bicyclic pyrimidinones and uses thereof |
07/03/2008 | WO2008060927A3 Hepatitis c virus inhibitors |
07/03/2008 | WO2008060927A2 Hepatitis c virus inhibitors |
07/03/2008 | WO2008014307A3 Inhibitors of undecaprenyl pyrophosphate synthase |
07/03/2008 | US20080161907 Stent coated with a sustained-release drug delivery and method for use thereof |
07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
07/03/2008 | US20080161405 Multivessel package containing polyol such as mannose |
07/03/2008 | US20080161391 Novel curcumin analogues and uses thereof |
07/03/2008 | US20080161376 Using antimycotic formulation containing propylene glycol, disodium edta, mineral oil, polyglyceryl-3-oleate, glyceryl monoisostearate, microcrystalline wax, silicon dioxide, methylparaben, propylparaben, butoconazole nitrate in water and sorbitol solution |
07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
07/03/2008 | US20080161350 Use of quinoline derivatives with anti-integrase effect and applications thereof |
07/03/2008 | US20080161324 Screening for effective drug combinations; single stranded RNA, flaviviridae and/or hepatic viruses; reducing side effects |
07/03/2008 | US20080161311 e.g. 2-(3,4-dichlorobenzyl)-9-hydroxy-3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,8-dione hydrochloride; AIDS, or as an anti-HIV agent; non-toxic, fewer side effects |
07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
07/03/2008 | US20080161302 Antifungal Agents |
07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
07/03/2008 | US20080161271 e.g. 9-Hydroxy-2-(2-methoxy-ethyl)-1,8-dioxo-1,8-dihydro-2H-pyrid[1,2-a]pyrazi ne-7-carboxylic acid 4-fluoro-banzylamide; Human T cell leukemia virus, Feline and Simian immunodeficiency virus inhibitor; side effects reduction |
07/03/2008 | US20080161264 N-{3-[3-(3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-exo-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}-4,4-difluorocyclohexanecarboxamide; with deuterium isotop; chemokine (C-C motif) CCR5 receptor antagonist; antiinflammatory agent, viricide; with other active ingredients; HIV, AIDS, multiple sclerosis |
07/03/2008 | US20080161263 Fusion proteins of Mycobacterium tuberculosis |
07/03/2008 | US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use |
07/03/2008 | US20080161254 Hcv inhibitors |
07/03/2008 | US20080161250 Topical treatment or prevention of ocular infections |
07/03/2008 | US20080161249 Use of Novel Antibacterial Compounds |
07/03/2008 | US20080161247 Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH or NADPH dependent enzymes and process thereof |
07/03/2008 | US20080161246 Cytochrome P450 Oxidase Inhibitors and Uses Thereof |
07/03/2008 | US20080161236 Therapeutic nucleic acid-3'-conjugates |
07/03/2008 | US20080160112 Pharmaceutical use of water-soluble fraction of graptopetalum |
07/03/2008 | US20080160089 Vaccine delivery compositions and methods of use |
07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
07/03/2008 | US20080160065 insert suitable for mammalian intravaginal, buccal, or intrarectal use; non-degradable hydrogel matrix |
07/03/2008 | US20080160046 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
07/03/2008 | US20080160045 Vaccines Comprising Aluminum Adjuvants and Histidine |
07/03/2008 | US20080160040 Using papillomavirus minor capsid protein as tool in generating neutralizing antibodies which prevent and treat papillomal infection |
07/03/2008 | US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response |
07/03/2008 | US20080160033 Novel Screening Method |
07/03/2008 | US20080160028 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas |
07/03/2008 | US20080160027 Chlamydia pneumoniae vaccine and methods for administering such a vaccine |
07/03/2008 | US20080160005 Interleukin-6 suppressive agent |
07/03/2008 | US20080159982 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients |
07/03/2008 | CA2684165A1 Oligonucleotide-prolyethylene glycol compound |
07/03/2008 | CA2673678A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
07/03/2008 | CA2673543A1 Multivalent pneumococcal polysaccharide-protein conjugate composition |
07/03/2008 | CA2673466A1 Substituted tetracycline compounds |
07/03/2008 | CA2673370A1 Substituted acetophenones useful as pde4 inhibitors |
07/03/2008 | CA2673183A1 Bicyclic pyrimidinones and uses thereof |
07/03/2008 | CA2673070A1 Method and system for enhancing self-treatment of onychomycosis |
07/03/2008 | CA2672640A1 Growth inhibition of microorganisms by lactic acid bacteria |
07/03/2008 | CA2672518A1 Organic compounds and their uses |
07/03/2008 | CA2672155A1 Use of xanthohumol or isoxanthohumol as an active substance for the prevention and/or control of liver diseases |
07/03/2008 | CA2670763A1 4-(1-amino-ethyl)-cyclohexylamine derivatives |
07/03/2008 | CA2664118A1 Protease inhibitors |
07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
07/02/2008 | EP1939290A2 Gene expression control |
07/02/2008 | EP1939278A1 Method for production of t cell population |
07/02/2008 | EP1939213A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
07/02/2008 | EP1939202A1 Novel adenine compound |
07/02/2008 | EP1939201A1 Novel adenine compound |
07/02/2008 | EP1939200A1 Novel adenine compound |
07/02/2008 | EP1939199A1 Novel adenine compound |
07/02/2008 | EP1939198A1 Novel adenine compound |
07/02/2008 | EP1938841A2 Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH+ or NADPH dependent enzymes and process thereof |
07/02/2008 | EP1938826A1 Use of nocardia rubra cell wall skeleton to produce medicaments for resisting human papilloma virus hpv |
07/02/2008 | EP1938824A1 Medicine, food and drink or feed containing sphingomyelin |
07/02/2008 | EP1937825A2 Modified 4'-nucleosides as antiviral agents |
07/02/2008 | EP1937710A1 Kinin b1 receptor peptide agonists and uses thereof |
07/02/2008 | EP1937678A1 Hiv integrase inhibitors |
07/02/2008 | EP1937655A1 Hiv-1 protease inhibitors, and methods of making and using them |
07/02/2008 | EP1937651A1 Nnrt inhibitors |
07/02/2008 | EP1937631A2 Hiv-1 protease inhibitors |
07/02/2008 | EP1937308A1 Synthetic polyvalent carbohydrates as components of microbicides |
07/02/2008 | EP1937284A1 Microbicidal dendrimer composition delivery system |
07/02/2008 | EP1937272A2 Benzodiazepines as hcv inhibitors |
07/02/2008 | EP1937257A1 Novel antibiotics comprising bis(1-aryl-5-tetraz0lyl)methane derivatives |
07/02/2008 | EP1937256A2 Antiviral therapy with carbohydrate binding agents |
07/02/2008 | EP1937235A2 Methods for treating viral infections using polyamine analogs |
07/02/2008 | EP1937228A1 Pharmaceutical composition based on a morpholinic antimycotic agent and a water-soluble film-forming agent for ungual and periungual application |
07/02/2008 | EP1596859B1 Treatment of diseases caused by ljungan virus by using pleconaril |
07/02/2008 | EP1509519B1 Crystalline fluoroquinolone arginine salt form |
07/02/2008 | EP1487791B1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate |
07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
07/02/2008 | EP1451181B1 Dimeric compounds and their use as anti-viral agents |
07/02/2008 | EP1427436B1 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
07/02/2008 | EP1423385B1 Intermediates for preparing neuraminidase inhibitor conjugates |
07/02/2008 | EP1265579B1 Container for linezolid intravenous solution |
07/02/2008 | EP1165057B1 Endodontic fibers and methods of use therefor |
07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
07/02/2008 | EP0667912B1 Defective adenovirus vectors and use thereof in gene therapy |